Current:Home > 新闻中心Family of explorer who died in the Titan sub implosion seeks $50M-plus in wrongful death lawsuit -ForexStream
Family of explorer who died in the Titan sub implosion seeks $50M-plus in wrongful death lawsuit
View
Date:2025-04-13 13:52:41
The family of a French explorer who died in a submersible implosion has filed a wrongful death lawsuit seeking more than $50 million that accuses the sub’s operator of gross negligence.
Paul-Henri Nargeolet was among five people who died when the Titan submersible imploded during a voyage to the famed Titanic wreck site in the North Atlantic in June 2023. No one survived the trip aboard the experimental submersible owned by OceanGate, a company in Washington state that has since suspended operations.
Known as “Mr. Titanic,” Nargeolet participated in 37 dives to the Titanic site, the most of any diver in the world, according to the lawsuit. He was regarded as one of the world’s most knowledgeable people about the famous wreck. Attorneys for his estate said in an emailed statement that the “doomed submersible” had a “troubled history,” and that OceanGate failed to disclose key facts about the vessel and its durability.
“The lawsuit further alleges that even though Nargeolet had been designated by OceanGate to be a member of the crew of the vessel, many of the particulars about the vessel’s flaws and shortcomings were not disclosed and were purposely concealed,” the attorneys, the Buzbee Law Firm of Houston, Texas, said in their statement.
A spokesperson for OceanGate declined to comment on the lawsuit, which was filed Tuesday in King County, Washington. The lawsuit describes Nargeolet as an employee of OceanGate and a crew member on the Titan.
Tony Buzbee, one of the attorneys on the case, said one goal of the lawsuit is to “get answers for the family as to exactly how this happened, who all were involved, and how those involved could allow this to happen.”
Concerns were raised in the aftermath of the disaster about whether the Titan was doomed due to its unconventional design and its creator’s refusal to submit to independent checks that are standard in the industry. Its implosion also raised questions about the viability and future of private deep-sea exploration.
The U.S. Coast Guard quickly convened a high-level investigation, which is ongoing. A key public hearing that is part of the investigation is scheduled to take place in September.
The Titan made its last dive on June 18, 2023, a Sunday morning, and lost contact with its support vessel about two hours later. After a search and rescue mission that drew attention around the world, the wreckage of the Titan was found on the ocean floor about 984 feet (300 meters) off the bow of the Titanic, about 435 miles (700 kilometers) south of St. John’s, Newfoundland.
OceanGate CEO and cofounder Stockton Rush was operating the Titan when it imploded. In addition to Rush and Nargeolet, the implosion killed British adventurer Hamish Harding and two members of a prominent Pakistani family, Shahzada Dawood and his son Suleman Dawood.
The company that owns the salvage rights to the Titanic is in the midst of its first voyage to the wreckage site in years. Last month, RMS Titanic Inc., a Georgia-based firm, launched its first expedition to the site since 2010 from Providence, Rhode Island.
Nargeolet was director of underwater research for RMS Titanic. One of the expeditions Nargeolet took was the first visit to the Titanic in 1987, shortly after its location was discovered, the lawsuit states. His estate’s attorneys described him as a seasoned veteran of underwater exploration who would not have participated in the Titan expedition if the company had been more transparent.
The lawsuit blames the implosion on the “persistent carelessness, recklessness and negligence” of Oceangate, Rush and others.
“Decedent Nargeolet may have died doing what he loved to do, but his death — and the deaths of the other Titan crew members — was wrongful,” the lawsuit states.
veryGood! (85)
Related
- Woman dies after Singapore family of 3 gets into accident in Taiwan
- Simu Liu Reveals the Secret to the People’s Choice Awards—and Yes, It’s Ozempic
- US senators to submit resolution condemning democratic backsliding in Hungary
- Premier Lacrosse League Championship Series offers glimpse at Olympic lacrosse format
- Intel's stock did something it hasn't done since 2022
- Colorado university mourns loss of two people found fatally shot in dorm; investigation ongoing
- Powerball winning numbers for Feb. 17 drawing: Jackpot worth over $300 million
- Sloane Stephens on her 'Bold' future: I want to do more than just say 'I play tennis.'
- The Daily Money: Spending more on holiday travel?
- Sloane Stephens on her 'Bold' future: I want to do more than just say 'I play tennis.'
Ranking
- Whoopi Goldberg is delightfully vile as Miss Hannigan in ‘Annie’ stage return
- Chris Brown says he was disinvited from NBA All-Star Celebrity Game due to controversies
- 2 officers, 1 first responder shot and killed at the scene of a domestic call in Minnesota
- Abortion rights opponents and supporters seize on report that Trump privately pushes 16-week ban
- Intel's stock did something it hasn't done since 2022
- Men's college basketball bubble winners and losers: TCU gets big win, Wake Forest falls short
- Bryce Harper wants longer deal with Phillies to go in his 40s, accepts move to first base
- 'True Detective' finale reveals the forces that killed those naked, frozen scientists
Recommendation
Federal appeals court upholds $14.25 million fine against Exxon for pollution in Texas
Prince William attends the BAFTAs solo as Princess Kate continues recovery from surgery
Zimbabwe’s vice president says the government will block a scholarship for LGBTQ+ people
Powerball winning numbers for Feb. 17 drawing: Jackpot worth over $300 million
EU countries double down on a halt to Syrian asylum claims but will not yet send people back
Sacramento State's Matt Masciangelo was hit an astounding 8 times in 9 at-bats
Jaromir Jagr’s return to Pittsburgh ends with his No. 68 being retired — and catharsis
FDA approves a drug to treat severe food allergies, including milk, eggs and nuts